Clinical Trials Browser

Terminated × lenvatinib × 30 days × Clear all

NCT05103904 2026-04-21

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular